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Increased expression of M1 and M2 phenotypic markers in
isolated microglia after four-day binge alcohol exposure in male
rats
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Hui Peng, Chelsea R.G. Nickell, Kevin Y. Chen, Justin A. McClain, and Kimberly Nixon*
University of Kentucky, College of Pharmacy, Department of Pharmaceutical Sciences, Lexington,
KY 40536, USA

Abstract

Author Manuscript

Microglia activation and neuroinflammation are common features of neurodegenerative
conditions, including alcohol use disorders (AUDs). When activated, microglia span a continuum
of diverse phenotypes ranging from classically activated, pro-inflammatory (M1) microglia/
macrophages to alternatively activated, growth-promoting (M2) microglia/macrophages.
Identifying microglia phenotypes is critical for understanding the role of microglia in the
pathogenesis of AUDs. Therefore, male rats were gavaged with 25% (w/v) ethanol or isocaloric
control diet every 8 h for 4 days and sacrificed at 0, 2, 4, and 7 days after alcohol exposure (e.g.,
T0, T2, etc.). Microglia were isolated from hippocampus and entorhinal cortices by Percoll density
gradient centrifugation. Cells were labeled with microglia surface antigens and analyzed by flow
cytometry. Consistent with prior studies, isolated cells yielded a highly enriched population of
brain macrophages/microglia (>95% pure), evidenced by staining for the macrophage/microglia
antigen CD11b. Polarization states of CD11b+CD45low microglia were evaluated by expression of
M1 surface markers, major histocompatibility complex (MHC) II, CD32, CD86, and M2 surface
marker, CD206 (mannose receptor). Ethanol-treated animals begin to show increased expression
of M1 and M2 markers at T0 (p = n.s.), with significant changes at the T2 time point. At T2,
expression of M1 markers, MHC-II, CD86, and CD32 were increased (p < 0.05) in hippocampus
and entorhinal cortices, while M2 marker, CD206, was increased significantly only in entorhinal
cortices (p < 0.05). All effects resolved to control levels by T4. In summary, four-day binge
alcohol exposure produces a transient increase in both M1 (MHC-II, CD32, and CD86) and M2
(CD206) populations of microglia isolated from the entorhinal cortex and hippocampus. Thus,
these findings that both pro-inflammatory and potentially beneficial, recovery-promoting
microglia phenotypes can be observed after a damaging exposure of alcohol are critically
important to our understanding of the role of microglia in the pathogenesis of AUDs.
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According to new Diagnostic and Statistical Manual V criteria, an even larger portion of the
U.S. population, nearly 14%, meets the diagnostic criteria for an alcohol use disorder (AUD)
in any given year (Grant et al., 2015). Excessive alcohol (ethanol) use, characteristic of an
AUD, causes significant neuropathology throughout the brain, including the limbic system,
cerebellum, and cerebral cortex, according to both human studies and animal models (Crews
& Nixon, 2009; de la Monte & Kril, 2014; Sullivan & Pfefferbaum, 2005). While human
imaging studies have shown that both white and gray matter loss occurs in a variety of brain
regions in alcoholics (Beresford et al., 2006; de la Monte & Kril, 2014; Mechtcheriakov et
al., 2007; Pfefferbaum et al., 1992; Sullivan & Pfefferbaum, 2005), animal models of AUDs
have been necessary to support the causal relationship between high blood alcohol
concentrations characteristic of binge/bender pattern drinking and neurodegeneration
(Collins, Corso, & Neafsey, 1996; Crews, Braun, Hoplight, Switzer, & Knapp, 2000; Crews
& Nixon, 2009; Hunt, 1993; Kelso, Liput, Eaves, & Nixon, 2011). Binge drinking has been
defined as imbibing 4 (women) or 5 (men) standard drinks within 2 h to produce blood
ethanol concentrations (BECs) greater than 0.08 mg/dL (NIAAA; 2017), whereas a bender
is repeated days of excessive intake including binge drinking. Over the last several years,
studies have revealed that excessive alcohol exposure results in immune activation in the
central nervous system (CNS), a phenomenon that several groups suggest is driving the
pathogenesis of AUDs (Chastain & Sarkar, 2014; Crews & Vetreno, 2014; Cui, Shurtleff, &
Harris, 2014; Davis & Syapin, 2004; Marshall et al., 2013; Vallés, Blanco, Pascual, &
Guerri, 2004).

Author Manuscript

Microglia are the myeloid-lineage, resident immune cells of the CNS that become activated
in response to insult (Ransohoff & Perry, 2009). Similar to what has been described in
macrophages, microglia are often characterized as two distinct activated phenotypes: the M1
pro-inflammatory/classically activated phenotype, and the M2 anti-inflammatory/alternative
activated phenotype (Benarroch, 2013; Beynon & Walker, 2012; Carson et al., 2007; C.
Colton & Wilcock, 2010; Graeber, 2010; Raivich et al., 1999). While the M2 phenotypes
promote tissue repair and phagocytosis of protein aggregates and cell debris, the M1
phenotypes are more likely to be detrimental to the brain by inducing neuronal toxicity
through secretion of pro-inflammatory cytokine and chemokine and production of reactive
oxygen species (ROS). Although we and others have documented the effect of ethanol on
various neuroimmune activation markers and microglia in animal models of alcohol use and
abuse (Alfonso-Loeches, Pascual-Lucas, Blanco, Sanchez-Vera, & Guerri, 2010; Blednov et
al., 2005; Crews, Zou, & Qin, 2011; Fernandez-Lizarbe, Pascual, & Guerri, 2009; Marshall
et al., 2013; McClain et al., 2011; Nixon, Kim, Potts, He, & Crews, 2008; Qin et al., 2008;
Suk, 2007; Vallés et al., 2004), specific phenotypic M1 versus M2 markers have not been
examined in the context of determining microglia phenotype. Therefore, the specific role of
microglia in alcoholic neuropathology remains unclear. Identifying microglia activation
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states (phenotypes) is critical for understanding the role of microglia in the pathogenesis of
AUDs.
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Microglia are routinely enumerated and classified by morphology and cell-surface markers
using immunohistochemistry, and indirectly through assessment of cytokine expression
(though multiple cell types could be the source, such as astroglia; Bedi, Smith, Hetz, Xue, &
Cox, 2013; Beynon & Walker, 2012; Colton & Wilcock, 2010). For example, upregulation
of ionized calcium binding adaptor molecule 1 (Iba-1) and monocyte chemotactic protein 1
(MCP1) immunoreactivity (He & Crews, 2008) and observation of proliferating microglia
(Dennis et al., 2013; Sutherland et al., 2013) in human alcoholic brain provide the most
compelling evidence for at least some level of activation, but neither of these phenomena are
associated specifically with an M1 state (Raivich et al., 1999). Our recent work using these
two methodologies has shown that four-day binge alcohol exposure, a model of an AUD,
shows that microglia are activated but potentially not to a classically activated or M1
phenotype (Marshall et al., 2013; McClain et al., 2011). However, the specific and wellaccepted phenotypic markers have not been examined. Therefore, the current study was
designed to use Percoll separation/enrichment followed by three-color flow cytometric
analysis of fluorescently labeled surface markers on microglia to enumerate microglia
phenotypes from different brain regions, 48 h after four-day binge alcohol exposure. The
fresh isolation of enriched cell suspensions enabled us to accurately quantify microglia
activation states in entire populations of cells from regions of interest (hippocampus and
entorhinal cortex) without reliance on manual morphometric counting of serial
immunohistochemistry slides.

Materials and Methods
Author Manuscript

Rat Model of an AUD

Author Manuscript

All procedures were approved by the University of Kentucky Institutional Animal Care and
Use Committee and adhered to the Guide for the Care and Use of Laboratory Animals
(NRC, 1996). Thirty-three adult, male Sprague Dawley rats (275–300 g, Charles River
Laboratories, Raleigh, NC) were pair-housed in a University of Kentucky AALAC
accredited vivarium with a 12-h light:dark cycle. Rats were allowed to acclimate to the
vivarium for 2 days followed by 3 days of handling before any experimentation. Except
during the binge periods when chow was removed, animals had ad libitum access to food
and water. Following acclimation, rats were gavaged with ethanol (25% ethanol w/v in
Vanilla Ensure Plus®, Abbott Laboratories, Abbott Park, IL; n = 17) or isocaloric control
diet (added dextrose; n = 16) every 8 h for 4 days following a procedure modified from
Majchrowicz (1975), as reported previously (Morris, Kelso, Liput, Marshall, & Nixon,
2010). Following an initial 5-g/kg ethanol dose, subsequent doses were titrated according to
a 6-point intoxication behavior scale. BECs were determined in serum from tail blood
collected 90 min following the seventh dose by an AM1 Alcohol Analyser (Analox, London,
UK). Starting 10 h after the last dose of ethanol, withdrawal was observed for 30 min every
4 h for 16 h. Behaviors were scored based on a scale modified from Majchrowicz (1975) but
identical to that reported previously (Morris et al., 2010).
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Microglia were isolated from brain tissue by Percoll gradient centrifugation as described
previously (Frank, Wieseler-Frank, Watkins, & Maier, 2006), with slight modification.
Based on the time course of microglia activation in this model of an AUD, rats were
humanely killed at 0, 2, 4, and 7 days following the last dose of ethanol (i.e., T0, T2, T4, and
T7): rats were deeply anesthetized and transcardially perfused with 0.9% NaCl containing
heparin. Brains were harvested and the hippocampus and entorhinal cortex were dissected
on ice. Tissue was finely minced with a razor blade and gently homogenized in Dulbecco’s
phosphate-buffered saline (DPBS), pH 7.4, then passed through a 70-μm nylon cell strainer
(VWR, Batavia, IL). Resulting homogenates were centrifuged at 400 × g for 6 min and cell
pellets were resuspended in 2 mL 50% isotonic Percoll (GE Healthcare, Piscataway, NJ).
Two milliliters of 50% isotonic Percoll was gently layered on top of 1 mL 70% layer and
then 1 mL 1× PBS was layered on top of the 50% Percoll layer. The density gradient was
centrifuged at 1200 × g for 45 min (minimum acceleration and brake) at 20 °C. Microglia
were collected from the interphase between the 70% and 50% isotonic Percoll phases (Frank
et al., 2006). Cells were washed in 1× PBS and then resuspended in sterile DPBS.
Microglia staining and flow cytometry

Author Manuscript

Microglia were surface-stained with conjugated monoclonal antibodies to assess microglia
purity (CD11b-FITC, BD Pharmingen, San Jose, CA; CD45-APC, eBioscience, San Diego,
CA) and M1 activation markers (CD86-PE, FcγRIII[CD32]-PE, or MHC-II-PE, BD
Pharmingen) as previous described (Bedi et al., 2013). For the M2 marker, microglia were
stained with rabbit anti-rat CD206 (Abcam, Cambridge, MA), followed by a secondary
incubation with donkey anti-rabbit-PE (BD Pharmingen). In brief, microglia were suspended
in 50-μL incubation buffer (1× PBS + 0.1% bovine serum albumin) for 30 min on ice, and
Fc receptors were blocked with anti-CD32 antibody (except for CD32 staining,
eBioscience). Cells were incubated with antibodies for 30 min on ice in the dark. Cells were
washed with 1× PBS and fixed with a formaldehyde-based fixation buffer (eBioscience
#00-8222) on ice.

Author Manuscript

Data were acquired with an Attune Acoustic Focusing Cytometer (ABI, Carlsbad, CA) and
analyzed with Attune Acoustic software (ABI). Before each run, the cytometer was
calibrated with commercially available beads. Fluorescence spillover compensation values
were generated using pooled non-stained cells and single-color staining as a control. Debris
and aggregates were eliminated from the analysis by forward- and side-scatter
characteristics. Myeloid cells identified as CD11b+ cells were divided into CD45low
microglia and a small CD45high subpopulation (Fig. 1A). Polarization states of
CD11b+CD45low microglia were evaluated for expression of M1 markers CD32, CD86, or
MHC-II and M2 marker, CD206 (Fig. 3A, Figs. 3–6). For each sample, approximately
10,000 singlets were analyzed.
Statistical analysis
All values are represented as mean ± SEM. To verify that alcohol exposure between time
point groups was relatively similar, subject data of BEC and mean dose per day were
analyzed by one-way ANOVA. As the primary question of interest in these studies is
Alcohol. Author manuscript; available in PMC 2018 August 01.
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whether the ethanol group differed from controls at each time point, planned comparisons
were performed. Therefore, all comparisons were two-factors, control versus ethanol groups
at each time point, and conducted via t tests. A p value <0.05 was accepted as statistically
significant.

Results
Binge data

Small CD45hi myeloid population increased after four-day binge

Author Manuscript

Myeloid cells were isolated from the hippocampus and entorhinal cortex at 0, 2, 4, and 7
days after alcohol exposure. These time points were selected based on our previous
observations of microglial activation according to PK-11195 receptor autoradiography,
microglia morphological change, and expression of cytokines in four-day binge ethanolexposed rats versus controls at these times (Marshall et al., 2013). A simple mechanical
dissociation was chosen to homogenize CNS tissue versus using an enzymatic digestion
procedure in order to better preserve the immunophenotype of microglia and macrophages.
Percoll-isolated cells were stained for CD11b (a component of complement receptor 3),
which is constitutively expressed by microglia and macrophages and thus can be used to
determine cell purity. Consistent with prior studies, isolated cells yielded highly enriched
microglia and macrophages for immediate functional characterization ex vivo (Frank et al.,
2006): over 95% pure as evidenced by staining for the microglia and macrophage antigen
CD11b (Fig. 1A).

Author Manuscript

Author Manuscript

During four days of alcohol exposure, rats received an overall mean dose of 9.9 ± 0.7
g/kg/day of ethanol, which produced a peak blood ethanol concentration of 396.1 ± 82.5
mg/dL, measured at the third day of exposure. Subject data for each time point are shown in
Table 1, and are generally similar between groups with the exception of the T0 BEC, which
was significantly less than other time points (F(3,12) = 17.65, p < 0.05). All other parameters
are similar between time points. BEC is higher than that observed with the same model
historically in the laboratory. However, the range of BEC values and the mean dose per day
are remarkably similar to that reported previously (Marshall et al., 2013; Morris et al.,
2010).

CD11b+ myeloid cells were further divided into microglia (CD11b+CD45low) and a small
population of CD11b+CD45high cells based on their CD45 expression (Bedi et al., 2013).
CD11b+CD45high cells have been described as endogenous CNS macrophages in a noninflammatory context (Ford, Goodsall, Hickey, & Sedgwick, 1995) or as a combination of
infiltrating monocytes/macrophages, neutrophils, and activated CNS microglia/macrophages
in CNS injury scenarios (Jin, Ishii, Bai, Itokazu, & Yamashita, 2012; Stirling & Yong,
2008). We observed a small population of CD11b+CD45high in hippocampus and entorhinal
cortex of both control and alcohol-exposed rats. The frequency of these cells increased
significantly in alcohol-exposed groups (3.42% ± 1.35 at T0, 4.64% ± 1.00 at T2) versus
controls (1.25% ± 0.42 at T0, 1.35% ± 0.36 at T2) in hippocampus as well as in the
entorhinal cortex in alcohol-exposed rats (2.28% ± 0.62 at T0, 6.85% ± 3.49 at T2) versus
controls (1.51% ± 0.64 at T0, 1.57% ± 0.40 at T2), while complementary changes in
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frequency of the majority CD11b+CD45low microglial population were also noted in
hippocampus at T2 (80.87% ± 7.88 in alcohol-exposed rats versus 93.02% ± 2.05 in control
rats) and entorhinal cortex at T2 (84.24% ± 6.98 in alcohol-exposed rats versus 92.74%
± 0.89 in control rats).
CD11b is constitutively expressed by microglia, though expression increases with microglia
activation (Hynes, 1992; Marshall et al., 2013; Morioka, Kalehua, & Streit, 1992). Four-day
binge alcohol exposure significantly increased the expression of CD11b on CD11b+CD45low
microglia in both hippocampus (Fig. 2A) and entorhinal cortex (Fig. 2B) at T2. Alcohol
exposure also increased CD45 expression on microglia in both hippocampus (Fig. 2C) and
entorhinal cortex (Fig. 2D) at T0, with the most dramatic changes at the T2 time point, all of
which resolved to control levels by T4.

Author Manuscript

Increased expression of neuroimmune activation markers on the surface of microglia after
four-day binge alcohol exposure

Author Manuscript

Activated microglia can be classified as either M1 or M2 based on morphology and/or cell
surface antigens (Beynon & Walker, 2012; Colton & Wilcock, 2010; Ransohoff & Perry,
2009). Markers such as major histocompatibility complex (MHC) II, CD86, CD16/32, and
iNOS have been used to identify M1-polarized cells (David & Kroner, 2011). M2 microglia,
however, express the macrophage mannose receptor 1 (MMR, or CD206) on the cell
membrane and Arginase-1, a prototypical M2 marker, intracellularly (Graeber, 2010;
Nimmerjahn, Kirchhoff, & Helmchen, 2005). To assess global microglia/macrophage
activation states after four-day binge alcohol exposure, we isolated myeloid cells from the
hippocampus and the entorhinal cortices at T0, T2, T4, and T7 days after alcohol exposure.
To characterize the activation profile of microglia (CD45low) and CNS macrophages
(CD45high) after alcohol exposure, these cells were analyzed for several M1 (MHC-II and
CD86, CD32) and M2 (CD206) surface markers (Fig. 3A).

Author Manuscript

Two markers involved in antigen presentation, MHC-II and CD86, were identified on both
CD11b+CD45low microglia and CD11b+CD45hi cell populations (Fig. 3A). For MHC-II, as
expected, the majority of microglia (CD11b+CD45low) were negative for MHC-II
expression. After four-day binge alcohol exposure, the frequency of the MHC-II+ cells
increased slightly but not significantly in both hippocampus and entorhinal cortex at T0 (p =
n.s.), with significant changes at the T2 time point (Fig. 3; p < 0.05). At T2, we observed
increased expression of MHC-II+ cells in the hippocampus (2.73% in control rats to 11.28%
in ethanol-exposed rats; p = 0.009, Fig. 3B) and in the entorhinal cortex (2.19% in control
rats to 11.52% in ethanol-exposed rats; p = 0.009, Fig. 3C), all of which resolved to control
levels by T4. The overall expression of MHC-II on CD11b+CD45high cells (macrophages or
neutrophils) is much higher than on CD11b+CD45low microglia. Ethanol exposure does not
affect the expression of MHC-II in the CD11b+CD45high cell population (Fig. 3D & E).
For CD86 expression, the majority of microglia (CD11b+CD45low) were negative for CD86
expression (Fig. 4). After four-day binge alcohol exposure, the frequency of the CD86+ cells
in microglia increased slightly at T0 (p = n.s.) only in entorhinal cortex (Fig. 4B), with the
most dramatic changes at the T2 time point in both hippocampus and entorhinal cortex (Fig.
4). At T2, we observed increased expression of CD86+ cells in the hippocampus (3.16% in
Alcohol. Author manuscript; available in PMC 2018 August 01.
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control rats to 9.14% in ethanol-exposed rats; p = 0.011, Fig. 4A), and in the entorhinal
cortex (2.48% in control rats to 9.23% in ethanol-exposed rats; p = 0.001, Fig. 4B), all of
which resolved to control levels by T4. The overall expression of CD86 in CD11b+CD45high
cells is much higher than CD11b+CD45low microglia (Fig. 4C & D). Ethanol exposure
increased the expression frequency of CD86 in the CD11b+CD45high cell population in
entorhinal cortex from 22.49% to 32.58% (p = 0.04).

Author Manuscript

While the functional role of the Fcγ receptors on microglia remains to be illuminated,
CD16/32 has been widely used as an M1 marker in the CNS (Bedi et al., 2013; Kigerl et al.,
2009). For CD32 (FcγRIII) expression, results showed that after four-day binge alcohol
exposure, the frequency of the CD32+ cells in CD11b+CD45low microglia increased slightly
at T0 (p = n.s.), with the most dramatic changes at the T2 time point (Fig. 5). At T2, we
observed increased expression of CD32+ cells in the hippocampus (16.16% in control rats to
41.56% in ethanol-exposed rats; p = 0.01, Fig. 5A), and in the entorhinal cortex (21.07% in
control rats to 47.74% in ethanol-exposed rats; p = 0.004, Fig. 5B). Although there was an
increased frequency of CD32+ cells in CD11b+CD45low microglia at T4 (from 21.55% in
control rats to 33.66% in ethanol-exposed rats), it was not significant in hippocampus (p =
0.20; Fig. 5A), though there was a solid trend in entorhinal cortex (from 18.32% in control
rats to 38.51% in ethanol-exposed rats; p = 0.055, Fig. 5B). The levels in ethanol-exposed
rats were identical to the levels in control rats by T7. The overall expression of CD32 on
CD11b+CD45high cells is much higher than on CD11b+CD45low microglia (Fig. 5C & D).
Ethanol exposure increased the expression frequency of CD32 in CD11b+CD45high cell
population in entorhinal cortex (from 49.47% to 69.21%, p = 0.035).

Author Manuscript

CD206, macrophage mannose receptor 1, is the prototypical anti-inflammatory surface
marker and has been used to identify M2 microglia in other CNS insults (Bedi et al., 2013;
Beynon & Walker, 2012; Cherry, Olschowka, & O’Banion, 2014; Kigerl et al., 2009). In this
study, it was used to evaluate the M2 marker expression on microglia/macrophages
following alcohol exposure. The results showed that after four-day binge alcohol exposure,
the frequency of CD206+ cells in CD11b+CD45low microglia in the hippocampus increased
at the T2 time point, from 1.55% in control rats to 16.94% in ethanol-exposed rats, (p =
0.105, Fig. 6A), and in the entorhinal cortex from 1.97% to 15.81% (p = 0.007, Fig. 6B), all
of which resolved to control levels by T4. The overall expression of CD206 on
CD11b+CD45high cells is much higher than on CD11b+CD45low microglia (Fig. 6). Ethanol
exposure did not affect the expression of CD206 on the CD11b+CD45high cell population
(Fig. 6C & D).

Author Manuscript

Discussion
In this study, Percoll gradient centrifugation was used to isolate myeloid cells, followed by
flow cytometric methods to evaluate the activation state (phenotype) of the macrophage/
microglia population in the hippocampus and entorhinal cortex in a four-day binge model of
an AUD. To our knowledge, this is the first report using these combined methodologies to
identify microglia phenotype within the alcohol research field. By using monoclonal
antibodies against surface antigens to identify macrophages/microglia and characterize their
polarization state, we found that alcohol exposure induces a significant increase of both
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classically activated M1 and alternatively activated M2 microglia in hippocampus and
entorhinal cortex after four-day binge alcohol exposure, with the most extensive changes at
T2. This method has been shown to provide reproducible, sensitive, and quantitative
measurement of microglia phenotypes in whole brain and/or brain regions of interest (Frank
et al., 2006).

Author Manuscript
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For cell isolation, we used mechanical dissociation of tissue followed by Percoll density
gradient centrifugation to rapidly isolate microglia and macrophages from brain tissue. This
non-enzymatic procedure allowed for the characterization of the cells without concern that
their surface features had been enzymatically altered during tissue processing (Frank et al.,
2006). This well-tested method has proven to be a powerful tool to study basic microglia
biology and microglia immunophenotype and/or activation state under pathological
conditions. The isolated cell population is not only sufficiently enriched with microglia and
macrophages while excluding other cell types such as astrocytes, but these microglia/
macrophages also maintain their functional responsiveness after isolation (Barrientos et al.,
2015; Frank, Baratta, Sprunger, Watkins, & Maier, 2007; Frank et al., 2006). Consistent with
prior studies, our analysis revealed that purity and enrichment efficiency of myeloid cell
suspensions yields over 95% CD11b+ cells (Fig. 1). Quiescent microglia typically display an
MHC II-negative and CD86-negative immunophenotype (Colton & Wilcock, 2010; Frank et
al., 2006; Guillemin & Brew, 2004). Flow cytometric analysis of isolated microglia from
control rat brain also demonstrated that MHC II and CD86 expression was very low in
control conditions (less than 3%), which provides additional evidence that the isolation
procedure preserves the in situ activation state of microglia. One potential limitation of the
study is that we used an anti-CD32 antibody to block Fc-mediated non-specific antibody
binding instead of an isotype control (an antibody raised against an antigen not present on
the cell type being analyzed). An isotype control will determine the non-specific binding of
antibody to Fc receptors and ensure the observed staining is due to specific binding rather
than an artifact. Our choice of the Fc receptor antibody to block nonspecific binding is
common in studies with multiple antibodies used. To further reduce non-specific antibody
binding, we also added bovine serum albumin to the staining buffer and titrated the antibody
concentrations. Both the M1 and M2 marker expression is low in the control animals, which
suggests that the background expression of these antibodies is very low. Without an isotype
control, we cannot fully determine the background of our antibodies used, but the results
generated from control and ethanol groups give us the relative quantification of the marker
expression between control and ethanol-exposure groups.
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Traditionally, the CNS has been described as an immune-privileged site, where the blood
brain barrier limits movement of peripheral immune cells into the CNS. However, the blood
brain barrier may be compromised by excessive alcohol consumption and become more
permissive to immune cell extravagation (Alikunju, Abdul Muneer, Zhang, Szlachetka, &
Haorah, 2011; Haorah, Knipe, Leibhart, Ghorpade, & Persidsky, 2005). Although there is no
evidence of blood brain barrier compromise in the four-day binge model used (Marshall et
al., 2013), a small population of CD11b+CD45high cells was observed in both the
hippocampus and entorhinal cortex, and the frequency of these cells increased in the
ethanol-exposed group versus control animals (Fig. 1B & C). These cells displayed higher
mean intensity values of CD11b and CD45 (Fig. 2) and a higher percentage of MHC-II+/
Alcohol. Author manuscript; available in PMC 2018 August 01.
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CD86+/CD32+/CD206 staining than the CD45low microglial population (Figs. 3–6).
CD11b+CD45high cells have been described as endogenous CNS macrophages in a noninflammatory context (Ford et al., 1995). In injured brains, CD11b+CD45high cells are likely
a mixed population of inflammatory myeloid cell types, such as infiltrating monocyte/
macrophages, activated CNS microglia/macrophages, and possibly a few dendritic cells and
neutrophils (Bedi et al., 2013). To further discriminate neutrophils from microglia/
macrophages, a neutrophil marker such as Gr-1 could be used to eliminate neutrophils from
this population before analysis.
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Phenotypic markers such as MHC-II, CD86, iNOS, and CD16/32 have been used widely to
identify M1-polarized cells (David & Kroner, 2011; Kigerl et al., 2009; Ponomarev,
Veremeyko, Barteneva, Krichevsky, & Weiner, 2011), while CD206 (MMR) and arginase-1
have been used to differentiate M2 microglia (Graeber, 2010; Kigerl et al., 2009;
Nimmerjahn et al., 2005). In this study, we chose to examine surface markers (MHC-II,
CD86, CD32, and CD206) versus the intracellular markers (such as iNOS and arginase-1) to
avoid permeabilization for intracellular staining to retain ability to sort live cells for future
functional experiments. Although the heterogeneity of microglia has been well described in
other neuroinflammatory diseases (Carson et al., 2007; Colton et al., 2006; Kigerl et al.,
2009; Mikita et al., 2011; Zhang & Gensel, 2014), we are the first to identify various
phenotypes of microglia under alcohol exposure using flow cytometric analysis of M1 and
M2 surface markers. Our results show that four-day binge alcohol exposure induced a
transient increase of classically activated M1 microglia (as indicated by the increased
expression of MHC-II, CD86, and CD32), as well as alternatively activated M2 microglia as
indicated by the increased expression of CD206.
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Evidence that ethanol activates microglia to a pro-inflammatory stage has emerged from
several studies showing increased expression of pro-inflammatory cytokines, chemokines,
and danger-associated molecular patterns (DAMPs) in human alcoholic brain as well as in
rodent models of AUDs (Antón et al., 2016; Blednov et al., 2012; Crews, Qin, Sheedy,
Vetreno, & Zou, 2013; Flatscher-Bader et al., 2005; Liu et al., 2006; Vetreno & Crews, 2012;
Vetreno, Qin, & Crews, 2013; Wang et al., 2015; see also Crews et al., 2006; Crews &
Vetreno, 2014; Robinson et al., 2014 for review). For example, chronic alcohol exposure
induces microglia expression of pro-inflammatory factors, including TNF-α, IL-1β, and
IL-6 (Boyadjieva & Sarkar, 2010; Fernandez-Lizarbe, Montesinos, & Guerri, 2013), factors
that are associated with alcohol drinking and preference (Bajo et al., 2014; Blednov et al.,
2012; Robinson et al., 2014). Intermittent exposure to alcohol in rodent models activates
microglia and stimulates production of pro-inflammatory and neurotoxic molecules
including NO and COX2, cytokines such as TNF-α and IL-1β, and chemokines including
MCP1 and MIP-1α and β (Alfonso-Loeches et al., 2010; Blanco & Guerri, 2007; He &
Crews, 2008; Pascual, Blanco, Cauli, Miñarro, & Guerri, 2007; Qin et al., 2008; Vallés et al.,
2004). In adult mice, chronic ethanol administration increases TNF-α levels in the brain and
potentiates the LPS-induced increase in IL-1β levels in the brain (Qin et al., 2008). Some of
the most compelling data for a role of innate immune activation in AUDs come from
evidence of increased DAMP signaling, specifically high mobility group box 1 (HMGB1),
which is evident in human brain tissue as well as animal models (Antón et al., 2016; Crews
et al., 2013; Vetreno & Crews, 2012; Vetreno et al., 2013; Wang et al., 2015). The increased
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expression of pro-inflammatory markers in these published studies supports the increase in
M1 phenotypic markers observed here (Figs. 3–5). The microglia morphological changes
were most robust on T2, which is also consistent with the increase in M1 marker expression
as well as the timeline of the acute phase of neuroinflammation following brain injury
(Ansari, 2015; Bedi et al., 2013; Ransohoff & Perry, 2009). Indeed, the relatively few effects
at T0 may be due, in part, to blunted immune and/or neuroimmune function during ethanol
intoxication (Aroor & Baker, 1998; Gano, Doremus-Fitzwater, & Deak, 2016; Goral,
Karavitis, & Kovacs, 2008). Intriguingly, however, our previous studies showed that the
same AUD model as used in the current experiments results in morphological changes in
microglia consistent with activation (cellular processes become shorter, broader, and less
branched while the somas exhibited hypertrophy), but without the induction of proinflammatory cytokines in entorhinal cortex or hippocampus (Marshall et al., 2013; McClain
et al., 2011), an observation confirmed by others (Zahr, Luong, Sullivan, & Pfefferbaum,
2010). Thus, based on the morphological, immunohistochemical, and ELISA data in these
reports, we concluded that microglia activation in this model was not pro-inflammatory
(Marshall et al., 2013). While the immunohistochemical approaches are necessary for the
assessment of cell morphology, flow cytometric analysis of the Percoll-enriched microglia
reveals the global activation state of the entire microglial population of the region examined.
For example, the increased expression of MHC-II in the current experiment was not
expected based on negative MHC-II immunohistochemistry in our prior report (Marshall et
al., 2013). However, immunohistochemistry is performed on only one out of every 12 brain
sections, which makes it theoretically possible that MHC-II+ cells could be missed,
especially if they were localized to a particular, small region (e.g., Ward et al., 2009).
Therefore, the flow cytometric technique used in these studies is proving to be a more
sensitive and quantitative measure, which may provide a more accurate characterization of
an entire cell population (Bedi et al., 2013; Ransohoff & Perry, 2009). Although the
observation of increased M1-like marker expression may appear contradictory, the ratio of
M1 to M2 microglia would better define the contribution of these different phenotypes to the
pro- or anti-inflammatory environment.
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The increase in M2 marker, CD206, was predicted by our previous work and hypotheses that
beneficial microglia may underlie plasticity and reparative responses following alcohol
insult (Marshall et al., 2013; McClain et al., 2011). Multiple approaches –
immunohistochemistry, morphology, and ELISAs of anti-inflammatory cytokines and
growth factors – supported the conclusion that microglia after four-day binge alcohol
exposure may be of the beneficial phenotype (Marshall et al., 2013; McClain et al., 2011).
Indeed, the fold change in the percentage of CD11b+/CD45lo cells expressing CD206 is
quite striking. When the current data are considered with our past work, namely ELISAs that
consistently show increases in anti-inflammatory cytokine and growth factor expression, the
data herein continue to support our hypothesis that microglia are of a beneficial phenotype.
The finding of M2-type of microglia, however, is not inconsistent with innate immune
induction via DAMPs eliciting primed microglia (Crews et al., 2013; Frank et al., 2016;
Weber, Frank, Tracey, Watkins, & Maier, 2015). There is significant overlap between M2like marker expression and primed microglia (Perry & Holmes, 2014; Ransohoff & Perry,
2009), and past work supports the idea that alcohol primes microglia (e.g., Qin et al., 2008),
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including in the 4-day binge model (Marshall, Geil, & Nixon, 2016). Therefore,
development of potential therapeutics that target microglia will need to be more specific than
merely “inhibiting microglial activation”. Ablating all microglia is often detrimental to brain
recovery processes, which supports the conclusion that maintaining some microglia
homeostatic functions or perhaps promoting the M2, reparative population, is necessary for
plasticity and regenerative mechanisms (Cherry et al., 2014; Colton, 2009; LalancetteHebert, Gowing, Simard, Weng, & Kriz, 2007; Szalay et al., 2016; Yenari, Kauppinen, &
Swanson, 2010). Therapeutic approaches that induce M2 polarization or specifically inhibit
the pathological or chronic M1-like responses may be indicated. It is important to note,
though, that some neuroimmune activation is necessary and perhaps beneficial; some TNF-α
induction is required to elicit protective M2 responses (e.g., Lambertsen et al., 2009; Turrin
& Rivest, 2006). It is possible that the increase in M1 markers reflects that point.
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Microglia activation is a dynamic process that generates complex, overlapping patterns of
surface marker expression in various neurodegenerative disease models (e.g., Hu et al.,
2012; Kigerl et al., 2009) and, as we now describe, for a model of an AUD as well.
Reproducible, quantitative measurement of microglia phenotypes in whole brains and/or
regions of interest have made important contributions to our understanding of microglial
biology in models of neurodegenerative and psychological diseases such as AUDs. This
novel result of increased M2-like cells is critical to our understanding of the role of
microglia in the development of and recovery from AUDs. Most especially, these data are
important because microglial activation is an emerging therapeutic target for antiinflammatory strategies in neurodegenerative disorders and CNS insults, including AUDs
(Crews & Vetreno, 2014; Crews et al., 2011; Cui et al., 2014). It is critical to understand the
phenotype of microglia induced by an insult in order to develop therapies specifically
targeting pathological aspects of the neuroimmune response, likely the chronic proinflammatory M1 response, while maintaining or promoting beneficial M2 responses. As
microglia phenotype has not been considered in the context of the pathogenesis of AUDs,
these findings have important implications for drug discovery efforts on the
pharmacotherapeutic treatment of AUDs.
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Highlights
•

Identifying microglia phenotypes is critical to understanding the role of
microglia in AUDs.

•

Flow cytometry of isolated microglia was used for the first time in alcohol
research.

•

Four-day binge alcohol exposure transiently increases M1 and M2
populations of microglia.
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Fig. 1. Two populations of CD11b+ myeloid cells were identified from adult rat brains after a
four-day binge alcohol exposure by flow cytometry
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At 0, 2, 4, and 7 days after the last dose of diet (i.e., T0, T2, T4, and T7), microglia were
isolated from hippocampal and entorhinal cortex homogenates through Percoll density
gradient centrifugation. Cells were labeled with microglia surface antigens and analyzed by
flow cytometry. A. Debris and aggregates were eliminated from the analysis by forward- and
side-scatter characteristics (small plots). Myeloid cells identified as CD11b+ singlets were
further divided into CD11b+CD45lo microglia (blue box) and a small CD11b+CD45hi cell
subpopulation (red box). B–E. The relative frequencies of CD11b+CD45hi cells (B & C) and
CD11b+CD45lo microglia (D & E) varied significantly between control and alcohol-exposed
rat hippocampus (B & D) and entorhinal cortex (C & E). *p < 0.05 versus control.
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Fig. 2. Mean fluorescent intensity (MFI) of CD11b and CD45 expression on CD11b+CD45lo
microglia

A–D. Data presented show MFI of CD11b (A & B) and CD45 (C & D) on CD11b+CD45lo
microglia isolated from control and alcohol-exposed rat hippocampus (A & C) and
entorhinal cortex (B & D) as a percent of control. *p < 0.05 versus respective control.
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Fig. 3. Increased expression of MHC-II on CD11b+CD45lo cells after a four-day binge alcohol
exposure
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A. MHC II+ cells were enumerated in CD11b+CD45lo microglia (blue box) and
CD11b+CD45hi cells (red box) after any remaining myelin debris and aggregates were
eliminated by exclusion gates based on scatter characteristics (small plots). B–E. The
percentage of MHC II+ cells within CD11b+CD45lo microglia (B & C) and CD11b+CD45hi
cells (D & E) varied significantly between control and alcohol-exposed rat hippocampus (B
& D) and entorhinal cortex (C & E). *p < 0.05 versus respective control.
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Fig. 4. Increased expression of CD86 on CD11b+CD45lo cells after a four-day binge alcohol
exposure

A–D. The percentage of CD86+ cells within CD11b+CD45lo microglia (A & B) and
CD11b+CD45hi cells (C & D) varied significantly between control and alcohol-exposed rat
hippocampus (A & C) and entorhinal cortex (B & D). *p < 0.05 versus respective control.
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Fig. 5. Increased expression of CD32 on CD11b+CD45lo cells after a four-day binge alcohol
exposure

A–D. The percentage of CD32+ cells within CD11b+CD45lo microglia (A & B) and
CD11b+CD45hi cells (C & D) varied significantly between control and alcohol-exposed rat
hippocampus (A & C) and entorhinal cortex (B & D). *p < 0.05 versus respective control.
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Fig. 6. Increased expression of CD206 on CD11b+CD45lo cells after four-day binge alcohol
exposure

A–D. The percentage of CD206+ cells within CD11b+CD45lo microglia (A & B) and
CD11b+CD45hi cells (C & D) varied significantly between control and alcohol-exposed rat
hippocampus (A & C) and entorhinal cortex (B & D). *p < 0.05 versus respective control.
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3
7
3
3

T0

T2

T4

T7

p < 0.05

*

BEC = Blood ethanol concentration

Controls N

3

3

7

4

ethanol-exposed N

459.7 ± 44.3

393.2 ± 26.0
3.3 ± 0.5

3.1 ± 0.6

3.1 ± 0.3

n/a

269.6 ± 3.4*
442.6 ± 43.9

Peak Withdrawal

BEC (mg/dL)
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Time Point (Days)

1.8 ± 0.7

1.2 ± 0.5

2.1 ± 0.9

n/a

Mean Withdrawal

9.6 ± 0.8

10.6 ± 0.6

9.7 ± 0.4

10.2 ± 1.0

Dose (g/kg/day)
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